SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Inotek Pharmaceuticals Corporation Presents Preclinical Data at ARVO Confirming That INO-8875 Lowers IOP by Increasing Outflow Through the Trabecular Meshwork